Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs

E-ISSN： 1873-4286|8|14|1255-1296

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.14, 2002-06, pp. : 1255-1296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Inhibitors of PDE4: a review of recent patent literature

By Odingo Joshua O

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 7, 2005-07 ,pp. : 773-787

Informa Healthcare

Access to resources Recommend Favorite

PDE7 inhibitors as new drugs for neurological and inflammatory disorders

By Gil Carmen Campillo Nuria E Perez Daniel I Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1127-1139

Informa Healthcare

Access to resources Recommend Favorite

Tryptase inhibitors: a novel class of anti-inflammatory drugs

By Numerof R.P. Simpson P.J. Tanaka R.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 811-818

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of TACE and Caspase-1 As Anti-inflammatory Drugs

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 2963-2977

Bentham Science Publishers

Access to resources Recommend Favorite